| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.3M | +28.8% |
| SG&A Expense | $10.5M | +29.3% |
| Operating Income | -$19.8M | -29.1% |
| Pre-tax Income | -$20.8M | -38.8% |
| Income Tax | $2K | +0.9% |
| Net Income | -$20.8M | -38.8% |
| EPS (Basic) | -$21.58 | -1240.4% |
| EPS (Diluted) | -$21.58 | -1240.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.5M | +47.0% |
| Current Assets | $9.3M | +40.7% |
| Total Assets | $9.3M | +26.9% |
| Current Liabilities | $6.2M | +81.5% |
| Stockholders' Equity | $3.2M | -20.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.8M | -20.3% |
| Financing Cash Flow | $17.5M | +269.5% |